Zynerba Pharmaceuticals (NASDAQ:ZYNE – Get Rating) announced its earnings results on Tuesday. The company reported ($0.18) EPS for the quarter, topping analysts’ consensus estimates of ($0.24) by $0.06, Yahoo Finance reports. Zynerba Pharmaceuticals Trading Up 2.4 % Shares of NASDAQ ZYNE opened at $0.42 on Wednesday. Zynerba Pharmaceuticals has a twelve month low of $0.39 […]
Zynerba Pharmaceuticals (NASDAQ:ZYNE – Get Rating) posted its quarterly earnings data on Tuesday. The company reported ($0.18) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.24) by $0.06, Yahoo Finance reports. Zynerba Pharmaceuticals Stock Up 2.4 % Shares of NASDAQ ZYNE opened at $0.42 on Wednesday. The company has a market […]
Zynerba Pharmaceuticals (NASDAQ:ZYNE – Get Rating) is scheduled to announce its earnings results on Friday, March 24th. Zynerba Pharmaceuticals Trading Down 3.2 % Shares of Zynerba Pharmaceuticals stock traded down $0.02 on Thursday, reaching $0.46. 160,447 shares of the company were exchanged, compared to its average volume of 330,585. The company has a market capitalization […]
Zynerba Pharmaceuticals (NASDAQ:ZYNE – Get Rating) is scheduled to issue its quarterly earnings data on Friday, March 24th. Zynerba Pharmaceuticals Stock Down 3.2 % Shares of NASDAQ:ZYNE traded down $0.02 during trading on Thursday, reaching $0.46. 160,447 shares of the company traded hands, compared to its average volume of 330,585. The company’s 50 day moving […]